Newsroom

Sorted by: Latest

-

Riassunto: L'Empire State Building festeggia i suoi primi 95 anni con una nuova e dolce esperienza pop-up firmata Ghirardelli

NEW YORK--(BUSINESS WIRE)--Sarà un appuntamento goloso quello organizzato presso la principale attrazione di New York: l'Empire State Building (ESB) oggi annuncia la collaborazione con la Ghirardelli Chocolate Company, la famosa gelateria e cioccolateria situata al piano terra dell'edificio, per creare un pop-up unico nel suo genere in occasione del 95° anniversario del grattacielo, presso la terrazza panoramica all'86° piano, tutti i giorni dal 10 aprile fino al 10 maggio compreso. Per festegg...
-

L’Empire State Building célèbre son 95e anniversaire avec une nouvelle expérience éphémère tout en douceur signée Ghirardelli

NEW YORK--(BUSINESS WIRE)--Une touche de douceur s’invite dans la principale attraction de New York. L’Empire State Building (ESB) a annoncé aujourd’hui son partenariat avec Ghirardelli Chocolate Company, la célèbre boutique de chocolats et de glaces située au rez-de-chaussée du bâtiment, pour proposer une expérience éphémère unique à l’occasion de son 95e anniversaire sur la terrasse d’observation du 86e étage, tous les jours du 10 avril au 10 mai. Pour marquer cet anniversaire historique, la...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Das Empire State Building feiert sein 95-jähriges Jubiläum mit einem süßen neuen Pop-up-Erlebnis von Ghirardelli

NEW YORK--(BUSINESS WIRE)--Die Top-Attraktion in New York City bietet etwas Süßes. Das Empire State Building (ESB) gab heute eine Zusammenarbeit mit der Ghirardelli Chocolate Company bekannt. So wird das beliebte Schokoladen- und Eisgeschäft im Erdgeschoss des Gebäudes anlässlich des 95. Jubiläums täglich vom 10. April bis 10. Mai mit einem einzigartigen Pop-up-Stand auf der Aussichtsplattform im 86. Stock vertreten sein. Zur Feier des runden Jubiläums kreierte der Ghirardelli Chocolate & I...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Upbound Group, Inc. Announces Timing of First Quarter 2026 Financial Results

PLANO, Texas--(BUSINESS WIRE)--Upbound Group, Inc. (the "Company" or "Upbound") (NASDAQ: UPBD), a technology and data-driven leader in accessible and inclusive financial solutions that address the evolving needs and aspirations of underserved consumers, today announced that it will report financial results for the first quarter of 2026 before the market open on April 30, 2026, followed by a conference call beginning at 9:00 a.m. ET to discuss the results. Interested parties can access a live we...
-

Verastem Oncology Announces Two-Year Median Follow-Up Data on AVMAPKI® FAKZYNJA® Combination Therapy (avutometinib capsules; defactinib tablets) in Recurrent Low-Grade Serous Ovarian Cancer at the SGO 2026 Annual Meeting on Women’s Cancers

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced two-year median follow-up data from the Phase 2 RAMP 201 clinical trial that evaluated AVMAPKI® FAKZYNJA® combination therapy (avutometinib capsules; defactinib tablets) in patients with recurrent low-grade serous ovarian cancer (LGSOC) will be presented today during an oral plenary session at the Society o...
-

ESAB Corporation Schedules First Quarter 2026 Earnings Release and Conference Call

NORTH BETHESDA, Md.--(BUSINESS WIRE)--ESAB Corporation Schedules First Quarter 2026 Earnings Release and Conference Call...
-

Pivot Bio avança na expansão de soluções inovadoras de nitrogênio para a agricultura brasileira

Minneapolis, MN e Goiania, Brasil--(BUSINESS WIRE)--A Pivot Bio, uma das principais empresas inovadoras de agtech do mundo, destacou hoje seu trabalho contínuo para levar sua tecnologia líder do setor de inoculantes biológicos nitrogenados dos Estados Unidos para a agricultura brasileira, em um momento de crescente volatilidade global dos fertilizantes. Tensões geopolíticas contínuas, incluindo interrupções que afetam rotas globais importantes de navegação, criaram incertezas nas cadeias de sup...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - December 09.04.2026 MDEC.LN IE0007FIJUO5 50,002.00 USD 1,378,207.57 27.563  ...